.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Julphar
Chubb
AstraZeneca
Cantor Fitzgerald
Novartis
Cipla
Fuji
Express Scripts
Citi

Generated: December 17, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 102 37 423

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer IngelheimOFEVnintedanib esylateCAPSULE;ORAL205832-001Oct 15, 2014RXYesNo► Subscribe► SubscribeTREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (IPF)
Boehringer IngelheimOFEVnintedanib esylateCAPSULE;ORAL205832-002Oct 15, 2014RXYesYes► Subscribe► SubscribeTREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (IPF)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist